24 results for «1435»
24 results
PCR Innovators Day - Innovations for valve treatment: new devices, new tools, new procedures
19 May 2022 – From EuroPCR 2022
Valvular heart disease is probably one of the most innovative areas in cardiovascular medicine at large: tremendous progress has been made both in terms of quality of life and mortality. Technology continues to evolve, as there are still many gaps to be filled, and it is...
Management of complex non-culprit multivessel disease after STEMI - LIVE case
16 May 2023 – From EuroPCR 2023
Analyze the case of a 69-year-old non-diabetic male patient with mild chronic kidney disease, acute inferior MI and primary PCI on the postero-lateral RCA, whose angiography showed diffuse disease on the proximal CX and second OM (QFR: 0.65), and an intermediate prox LAD lesion (QFR: 0.90).
IVUS...
Other coronary interventions: SSO2, angioPy & more
16 May 2024 – From EuroPCR 2024
This session showcases a diverse array of innovative coronary interventions and technologies, including the use of super-saturated oxygen therapy in STEMI, the validation of intracoronary flow velocity measurement, the application of laser and optics-based coronary intravascular lithotripsy, and the development of contrast-free and X-ray-free PCI techniques....
Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery (PROCTOR)
03 Nov 2025
Kalaivani Mahadevan and Trisha Singh provide their take on the PROCTOR study presented by Ruben de Winter at TCT 2025, in San Francisco.
Author
Author
- ← previous
- 1
- 2
- next →